Avenue Therapeutics Inc. buy Maxim Group
Start price
11.12.23
/
50%
€0.13
Target price
11.12.24
€0.70
Performance (%)
-16.72%
Price
25.04.24
€0.11
Summary
This prediction is currently active. The price of Avenue Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -16.72%. This prediction currently runs until 11.12.24. The prediction end date can be changed by Maxim_Group at any time. Maxim_Group has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Avenue Therapeutics Inc. | - | - |
| iShares Core DAX® | -0.922% | -1.993% |
| iShares Nasdaq 100 | 0.371% | -0.868% |
| iShares Nikkei 225® | 2.224% | -5.187% |
| iShares S&P 500 | -0.026% | -0.918% |
Comments by Maxim_Group for this prediction
In the thread Avenue Therapeutics Inc. diskutieren
Avenue Therapeutics, Inc. (NASDAQ: ATXI) is now covered by analysts at Maxim Group. They set a "buy" rating and a $0.75 price target on the stock.
Ratings data for ATXI provided by MarketBeat